Core treatment for improving microencapsulability in simple gelatin coacervation method. 1985

J Okada, and A Kusai, and S Ueda
Product Development Laboratories, Sankyo Co. Ltd, Tokyo, Japan.

In microencapsulation by way of simple coacervation by gelatin, some core materials are encapsulated easily, whilst others are difficult to encapsulate or show an encapsulability dependent on the coacervation-inducing agent. The treatment of core materials to improve encapsulability was studied. It was found that core particle encapsulability can be improved by recrystallization from aqueous solution of an ionic polymer. Electrophoresis, microscopical observation and pH dependency of encapsulability of recrystallized cores revealed that the electrostatic attractive force between gelatin molecules in solution and a polymer attached to the core particle cause gelatin adsorption on the core surface to result in a great improvement in encapsulability.

UI MeSH Term Description Entries
D002225 Carbazilquinone An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. Carboquinone,Carboquone,Esquinon
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

J Okada, and A Kusai, and S Ueda
February 1983, The Journal of pharmacy and pharmacology,
J Okada, and A Kusai, and S Ueda
January 2003, Biomacromolecules,
J Okada, and A Kusai, and S Ueda
January 2002, Journal of microencapsulation,
J Okada, and A Kusai, and S Ueda
August 2004, Colloids and surfaces. B, Biointerfaces,
J Okada, and A Kusai, and S Ueda
September 1990, Optometry and vision science : official publication of the American Academy of Optometry,
J Okada, and A Kusai, and S Ueda
February 2016, Materials science & engineering. C, Materials for biological applications,
J Okada, and A Kusai, and S Ueda
April 1999, Drug development and industrial pharmacy,
J Okada, and A Kusai, and S Ueda
August 2007, Colloids and surfaces. B, Biointerfaces,
J Okada, and A Kusai, and S Ueda
July 1990, Journal of electron microscopy technique,
J Okada, and A Kusai, and S Ueda
January 1998, Radiation medicine,
Copied contents to your clipboard!